Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/28/2010US20100273776 Inhibition of alpha-synuclein toxicity
10/28/2010US20100273774 Indolymaleimide derivatives
10/28/2010US20100273773 Dibenzoazepine and dibenzooxazepine trpa1 agonists
10/28/2010US20100273772 Bisaryl Alkynylamides as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5 (MGLUR5)
10/28/2010US20100273771 Oxadiazole derivatives active on sphingosine-1-phosphate (sip)
10/28/2010US20100273770 1, 2, 4 -oxadiazole compounds for the treatment of autoimmune diseases
10/28/2010US20100273769 Composition and method for the treatment of parkinson's disease
10/28/2010US20100273768 Inhibitors of Bruton's Tyrosine Kinase
10/28/2010US20100273767 Modulators of 5-ht receptors and methods of use thereof
10/28/2010US20100273766 Substituted oxindol derivatives, medicaments containing said derivatives and use thereof
10/28/2010US20100273765 Rifamycin analogs and uses thereof
10/28/2010US20100273764 Inhibitors of pi3 kinase and/or mtor
10/28/2010US20100273763 Organometallic complexes as therapeutic agents
10/28/2010US20100273762 Method of combating infection
10/28/2010US20100273761 Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis
10/28/2010US20100273760 Topical Pharmaceutical Formulations And Methods Of Treatment
10/28/2010US20100273759 Progesterone antagonists
10/28/2010US20100273758 Sulfonamide Derivatives For The Treatment Of Diseases
10/28/2010US20100273757 Pyrazine derivatives useful as adenosine receptor antagonists
10/28/2010US20100273756 Adjunctive formulation and methods for palliation of fine wrinkles, mottled hyperpigmentation, tactile roughness of facial skin and related disorders
10/28/2010US20100273755 Diamide compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
10/28/2010US20100273754 Organic compounds
10/28/2010US20100273753 Organic compounds
10/28/2010US20100273752 Mequitazine for treating or preventing pathologies involving histamine h4 receptors
10/28/2010US20100273751 Substituted benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
10/28/2010US20100273750 Serotonin receptor antagonists for treating arthritis
10/28/2010US20100273749 Method for Treating Dry-Eye Syndrome
10/28/2010US20100273748 Antimicrobial therapy
10/28/2010US20100273747 Freeze-Dried Composition of Active Substances
10/28/2010US20100273746 Pharmaceutical formulations containing tolperisone
10/28/2010US20100273745 Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors
10/28/2010US20100273744 Compounds
10/28/2010US20100273743 Morpholin-4-ium 4 methoxyphenyl (morpholino) phosphinodithioate (gyy4137) as a novel vasodilator agent
10/28/2010US20100273742 Pharmacologically Active Agents Containing Esterified Phosphonates and Methods for Use Thereof
10/28/2010US20100273741 Apparatus and Methods for Adipose Tissue Detection
10/28/2010US20100273740 Phospholipids for the Treatment of Infection by Togaviruses, Herpes Viruses and Coronaviruses
10/28/2010US20100273739 Aminotetraline Derivatives, Pharmaceutical Composition, Containing Them, and Their Use in Therapy
10/28/2010US20100273738 Integrated patient management and control system for medication delivery
10/28/2010US20100273737 Supplementary food composition for reducing body odor
10/28/2010US20100273735 Soluble, highly branched glucose polymers for enteral and parenteral nutrition and for peritoneal dialysis
10/28/2010US20100273734 Derivatives of Hyaluronic Acids
10/28/2010US20100273733 HIV Treatment
10/28/2010US20100273732 Combination methods of treating cancer
10/28/2010US20100273731 Medium-Chain Length Fatty Acids, Salts and Triglycerides in Combination with Gemcitabine for Treatment of Pancreatic Cancer
10/28/2010US20100273730 Self-emulsifying pharmaceutical compositions of hydrophilic drugs and preparation thereof
10/28/2010US20100273729 Compositions Comprising Compounds Of Natural Origin For Damaged Skin
10/28/2010US20100273728 Formulations For The Oral Administration of Therapeutic Agents and Related Methods
10/28/2010US20100273727 Oral administration composition
10/28/2010US20100273726 Methicillin-resistant staphylococcus aureus active metabolites isolated from laurus nobilis and combinations thereof
10/28/2010US20100273725 Novel compounds useful in therapeutic and cosmetic methods
10/28/2010US20100273724 Pegylated ion channel modulating compounds
10/28/2010US20100273716 New uses for amino acid anticonvulsants
10/28/2010US20100273714 Peptide compounds for treating refractory status epilepticus
10/28/2010US20100273711 Individualized cancer treatments
10/28/2010US20100273707 Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells
10/28/2010US20100273703 Co-Therapy For Diabetic Conditions
10/28/2010US20100273650 Fungicidal Mixtures Comprising a Substituted 3-Hydroxymethylpyridine and a Further Fungicidal Compound
10/28/2010US20100273265 for inducing differentiation into retinal photoreceptor cells; for preventing/treating/suppressing progression of retinal diseases; retinitis pigmentosa, senile macular degeneration, diabetic retinopathy, retinal detachment, glaucoma and retinal vessel occlusion
10/28/2010US20100272838 Compositions comprising siraitia grosvenori extracts and methods for the treatment of infection
10/28/2010US20100272834 Freeze-Dried Molded Article Containing Magnesium Ascorbyl Phosphate
10/28/2010US20100272833 Topical compositions for anti-aging and methods of using same
10/28/2010US20100272832 Topical compositions for anti-aging and methods of using same
10/28/2010US20100272823 Pulmonary delivery particles comprising water insoluble or crystalline active agents
10/28/2010US20100272822 Nanocell drug delivery system
10/28/2010US20100272818 Compositions and methods comprising terpenes or terpene mixtures selected from thymol, eugenol, geraniol, citral, and l-carvone
10/28/2010US20100272815 Amorphous form of tapentadol hydrochloride
10/28/2010US20100272814 Method and means for producing bronchorelaxation
10/28/2010US20100272813 Nanoparticle-mediated treatment for inflammatory diseases
10/28/2010US20100272811 Complex of trospium and pharmaceutical compositions thereof
10/28/2010US20100272808 Shell-and-Core Dosage Form Approaching Zero-Order Drug Release
10/28/2010US20100272807 Sustained release aminopyridine composition
10/28/2010US20100272806 Compositions and Methods for Treating and Preventing Urolithiasis and Conditions Associated Therewith
10/28/2010US20100272804 Oxidized cationic polysaccharide-based polymer tissue adhesive for medical use
10/28/2010US20100272801 Pharmaceutical compositions of amlodipine and valsartan
10/28/2010US20100272800 Orally disintegrating olanzapine tablet
10/28/2010US20100272798 Controlled release preparation
10/28/2010US20100272797 Pharmaceutical Composition for Treating Hepatitis C Virus Infection Comprising HMG-COA Reductase Inhibitor and Bile Acid
10/28/2010US20100272796 Sustained release aminopyridine composition
10/28/2010US20100272795 Sustained release aminopyridine composition
10/28/2010US20100272794 Pharmaceutical composition of memantine
10/28/2010US20100272793 Controlled Release Hydraliazine Formulations
10/28/2010US20100272791 Composition having effect on treatment and prevention of dry eye syndrome
10/28/2010US20100272790 Methods of Treating Skin
10/28/2010US20100272787 Amethod of treating neurodegenerative diseases
10/28/2010US20100272783 Methods of Treating Infections of the Nail
10/28/2010US20100272781 Sugar Free Chewable Tablets
10/28/2010US20100272780 CELL LINES THAT PRODUCE PROSTAGLANDIN F2 ALPHA (PGF2a) AND USES THEREOF
10/28/2010US20100272779 Progesterone-containing compositions and devices
10/28/2010US20100272778 Stents having controlled elution
10/28/2010US20100272775 Immobilized biologically active entities having a high degree of biological activity following sterilization
10/28/2010US20100272774 Devices and methods for delivery of bioactive agents
10/28/2010US20100272773 Use of Drug Polymorphs to Achieve Controlled Drug Delivery From a Coated Medical Device
10/28/2010US20100272768 Compositions and methods for cell killing
10/28/2010US20100272763 Skin external preparation and method of producing the same
10/28/2010US20100272762 Freeze-Dried Coated Molded Article
10/28/2010US20100272752 Vaccine for viruses that cause persistent or latent infections
10/28/2010US20100272738 Anti-ox40l antibodies and methods using same
10/28/2010US20100272737 Novel Peptides and Protein and Uses Thereof
10/28/2010US20100272726 Assays, methods and means
10/28/2010US20100272722 Therapeutic uses of inhibitors of RTP801
1 ... 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 2050 ... 7860